The DOI matches its Crossref record; 220 of the 220 references it cites were found in a registry or an index.
Tailoring to RB: tumour suppressor status and therapeutic response
Open accessAbstract
The retinoblastoma tumour suppressor (RB) is a crucial regulator of cell-cycle progression that is invoked in response to a myriad of anti-mitogenic signals. It has been hypothesized that perturbations of the RB pathway confer a synonymous proliferative advantage to tumour cells; however, recent findings demonstrate context-specific outcomes associated with such lesions. Particularly, loss of RB function is associated with differential response to wide-ranging therapeutic agents. Thus, the status of this tumour suppressor may be particularly informative in directing treatment regimens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
Paik, S., Shak, S., Tang, G., Kim, C., Baker, J., Cronin, M., Baehner, F. L., Walker, M. G., Watson, D., Park, T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041588 · Cited by 6,277
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“In both contexts, upregulation of p16 INK4A is considered to be part of a senescence programme that limits inappropriate proliferation and tumorigenesi”
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
The human papilloma virus-16 E7-oncoprotein is able to bind to the retinoblastoma gene product
Dyson, N., Howley, P. M., Münger, K., & Harlow, E. (1989) · Science · doi:10.1126/science.2537532 · Cited by 3,017 · cited 1×
“Third, RB inactivation is mediated by and cooperates with oncogenes that contribute to human cance”
A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751
Paik, S., Tang, G., Shak, S., Kim, C., Baker, J., Kim, W., Cronin, M., Baehner, F. L., Watson, D., Bryant, J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.7985 · Cited by 2,579
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278 · cited 1×
“p16 INK4A is a marker for senescence and is required for the establishment of cell-cycle arrest, whereas RB loss is sufficient to mediate escape from senescenc”
Sotiriou, C., Wirapati, P., Loi, S., Harris, A., Fox, S., Smeds, J., Nordgren, H., Farmer, P., Praz, V., Haibe-Kains, B., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj052 · Cited by 2,063
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., et al. (2006) · Nature · doi:10.1038/nature05268 · Cited by 1,986
Expression of recessive alleles by chromosomal mechanisms in retinoblastoma
Cavenee, W. K., Dryja, T. P., Phillips, R. A., Benedict, W. F., Godbout, R., Gallie, B. L., Murphree, A. L., Strong, L. C., & White, R. L. (1983) · Nature · doi:10.1038/305779a0 · Cited by 1,920
The RB and p53 pathways in cancer
Sherr, C. J., & McCormick, F. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00102-2 · Cited by 1,690
Senescence in premalignant tumours
Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A. J., Barradas, M., Benguría, A., Zaballos, A., Flores, J. M., Barbacid, M., et al. (2005) · Nature · doi:10.1038/436642a · Cited by 1,482
To cycle or not to cycle: a critical decision in cancer
Malumbres, M., & Barbacid, M. (2001) · Nature Reviews Cancer · doi:10.1038/35106065 · Cited by 1,468
Dolma, S., Lessnick, S. L., Hahn, W. C., & Stockwell, B. R. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00050-3 · Cited by 1,446
The Concept of Synthetic Lethality in the Context of Anticancer Therapy
Kaelin, W. G. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1691 · Cited by 1,379
(2011) · Hepatogastroenterology · doi:10.5754/hge11155 · Cited by 1,257
Fry, D. W., Harvey, P. J., Keller, P. R., Elliott, W. L., Meade, M., Trachet, E., Albassam, M., Zheng, X., Leopold, W. R., Pryer, N. K., et al. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1427.3.11 · Cited by 1,236
Oncogene-induced senescence as an initial barrier in lymphoma development
Braig, M., Lee, S., Loddenkemper, C., Rudolph, C., Peters, A. H. F. M., Schlegelberger, B., Stein, H., Dörken, B., Jenuwein, T., & Schmitt, C. A. (2005) · Nature · doi:10.1038/nature03841 · Cited by 1,220
Carter, S. L., Eklund, A. C., Kohane, I. S., Harris, L. N., & Szallasi, Z. (2006) · Nature Genetics · doi:10.1038/ng1861 · Cited by 1,193
A p16 INK4a -Insensitive CDK4 Mutant Targeted by Cytolytic T Lymphocytes in a Human Melanoma
Wölfel, T., Hauer, M., Schneider, J., Serrano, M., Wölfel, C., Klehmann-Hieb, E., De Plaen, E., Hankeln, T., Meyer zum Büschenfelde, K.-H., & Beach, D. (1995) · Science · doi:10.1126/science.7652577 · Cited by 1,154
The Rb/E2F pathway: expanding roles and emerging paradigms
Harbour, J. W., & Dean, D. C. (2000) · Genes & Development · doi:10.1101/gad.813200 · Cited by 1,153 · cited 1×
“In this context, RB mediates transcriptional repression dependent on histone deacetylases, SWI/SNF chromatin-remodelling enzymes and additional chromatin modifier”
E2F integrates cell cycle progression with DNA repair, replication, and G 2 /M checkpoints
Ren, B., Cam, H., Takahashi, Y., Volkert, T., Terragni, J., Young, R. A., & Dynlacht, B. D. (2002) · Genes & Development · doi:10.1101/gad.949802 · Cited by 1,125
Lundberg, A. S., & Weinberg, R. A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.2.753 · Cited by 1,067
Harbour, J. W., Luo, R. X., Santi, A. D., Postigo, A. A., & Dean, D. C. (1999) · Cell · doi:10.1016/s0092-8674(00)81519-6 · Cited by 1,057
Regulation of retinoblastoma protein functions by ectopic expression of human cyclins
Hinds, P. W., Mittnacht, S., Dulic, V., Arnold, A., Reed, S. I., & Weinberg, R. A. (1992) · Cell · doi:10.1016/0092-8674(92)90249-c · Cited by 995
A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells
Lee, J.-S., Heo, J., Libbrecht, L., Chu, I.-S., Kaposi-Novak, P., Calvisi, D. F., Mikaelyan, A., Roberts, L. R., Demetris, A. J., Sun, Z., et al. (2006) · Nature Medicine · doi:10.1038/nm1377 · Cited by 953
Nevins, J. R. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.7.699 · Cited by 922
Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16
Lukas, J., Parry, D., Aagaard, L., Mann, D. J., Bartkova, J., Strauss, M., Peters, G., & Bartek, J. (1995) · Nature · doi:10.1038/375503a0 · Cited by 899
Regulation of the INK4b–ARF–INK4a tumour suppressor locus: all for one or one for all
Gil, J., & Peters, G. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1987 · Cited by 843
Loi, S., Haibe-Kains, B., Desmedt, C., Lallemand, F., Tutt, A. M., Gillet, C., Ellis, P., Harris, A., Bergh, J., Foekens, J. A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.1522 · Cited by 837
Cyclin D-dependent kinases, INK4 inhibitors and cancer
Ortega, S., Malumbres, M., & Barbacid, M. (2002) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(02)00037-9 · Cited by 778
Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis.
Qin, X. Q., Livingston, D. M., Kaelin, W. G., & Adams, P. D. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.10918 · Cited by 756
The retinoblastoma tumour suppressor in development and cancer
Classon, M., & Harlow, E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc950 · Cited by 738
The E2F transcriptional network: old acquaintances with new faces
Dimova, D. K., & Dyson, N. J. (2005) · Oncogene · doi:10.1038/sj.onc.1208612 · Cited by 715
Matrix metalloproteinases in tumour invasion and metastasis
Curran, S., & Murray, G. I. (1999) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199911)189:3<358::aid-path452>3.0.co;2-1 · Cited by 661
Gillett, C., Fantl, V., Smith, D., Fisher, C., Bartek, J. J., Dickson, C., Barnes, D. M., & Peters, G. (1994) · PubMed · Cited by 661
Sherr, C. J., & Weber, J. D. (2000) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)00038-6 · Cited by 654
Development of the 21-Gene Assay and Its Application in Clinical Practice and Clinical Trials
Sparano, J. A., & Paik, S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.1068 · Cited by 617
Pocket proteins and cell cycle control
Cobrinik, D. (2005) · Oncogene · doi:10.1038/sj.onc.1208619 · Cited by 601
Ishida, S., Huang, E., Zuzan, H., Spang, R., Leone, G., West, M., & Nevins, J. R. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.14.4684-4699.2001 · Cited by 596
Inactivation of the p53 pathway in retinoblastoma
Laurie, N. A., Donovan, S. L., Shih, C.-S., Zhang, J., Mills, N., Fuller, C., Teunisse, A., Lam, S., Ramos, Y., Mohan, A., et al. (2006) · Nature · doi:10.1038/nature05194 · Cited by 595
Biological activities and molecular targets of the human papillomavirus E7 oncoprotein
Münger, K., Basile, J. R., Duensing, S., Eichten, A., Gonzalez, S. L., Grace, M., & Zacny, V. L. (2001) · Oncogene · doi:10.1038/sj.onc.1204860 · Cited by 588
Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry
Sage, J., Miller, A. L., Pérez-Mancera, P. A., Wysocki, J. M., & Jacks, T. (2003) · Nature · doi:10.1038/nature01764 · Cited by 538
Horowitz, J. M., Park, S. H., Bogenmann, E., Cheng, J. C., Yandell, D. W., Kaye, F. J., Minna, J. D., Dryja, T. P., & Weinberg, R. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.7.2775 · Cited by 530
Discovery of a potent and selective inhibitor of cyclin-dependent kinase 4/6
Toogood, P. L., Harvey, P. J., Repine, J. T., Sheehan, D. J., VanderWel, S. N., Zhou, H., Keller, P. R., McNamara, D. J., Sherry, D., Zhu, T., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049354h · Cited by 513
Distinct and Overlapping Roles for E2F Family Members in Transcription, Proliferation and Apoptosis
DeGregori, J., & Johnson, D. (2006) · Current Molecular Medicine · doi:10.2174/1566524010606070739 · Cited by 498
Cycling to Cancer with Cyclin D1
Diehl, J. A. (2002) · Cancer Biology & Therapy · doi:10.4161/cbt.72 · Cited by 475
Growth suppression by p16ink4 requires functional retinoblastoma protein
Medema, R. H., Herrera, R. E., Lam, F., & Weinberg, R. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.14.6289 · Cited by 433
A revised picture of the E2F transcriptional network and RB function
Stevaux, O., & Dyson, N. J. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00388-5 · Cited by 428
Direct coupling of the cell cycle and cell death machinery by E2F
Nahle, Z., Polakoff, J., Davuluri, R. V., McCurrach, M. E., Jacobson, M. D., Narita, M., Zhang, M. Q., Lazebnik, Y., Bar-Sagi, D., & Lowe, S. W. (2002) · Nature Cell Biology · doi:10.1038/ncb868 · Cited by 421
Putting the stress on senescence
Serrano, M., & Blasco, M. A. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00278-7 · Cited by 413
Cyclin D1 in Breast Cancer Pathogenesis
Arnold, A., & Papanikolaou, A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.064 · Cited by 411
Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation
Wu, C.-H., van Riggelen, J., Yetil, A., Fan, A. C., Bachireddy, P., & Felsher, D. W. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701953104 · Cited by 403
Agami, R., & Bernards, R. (2000) · Cell · doi:10.1016/s0092-8674(00)00010-6 · Cited by 390
Control of pRB phosphorylation
Mittnacht, S. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80057-9 · Cited by 389
Lukas, J., Bartkova, J., Rohde, M., Strauss, M., & Bartek, J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.5.2600 · Cited by 366
Cyclin D1: polymorphism, aberrant splicing and cancer risk
Knudsen, K. E., Diehl, J. A., Haiman, C. A., & Knudsen, E. S. (2006) · Oncogene · doi:10.1038/sj.onc.1209371 · Cited by 363
Self-citationGenetic Origin of Mutations Predisposing to Retinoblastoma
Cavenee, W. K., Hansen, M. F., Nordenskjold, M., Kock, E., Maumenee, I., Squire, J. A., Phillips, R. A., & Gallie, B. L. (1985) · Science · doi:10.1126/science.3983638 · Cited by 359
Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein
Peeper, D. S., Upton, T. M., Ladha, M. H., Neuman, E., Zalvide, J., Bernards, R., DeCaprio, J. A., & Ewen, M. E. (1997) · Nature · doi:10.1038/386177a0 · Cited by 357
Retinoblastoma protein partners
(2001) · Advances in Cancer Research · doi:10.1016/s0065-230x(01)82001-7 · Cited by 349
AR, the cell cycle, and prostate cancer
Balk, S. P., & Knudsen, K. E. (2008) · Nuclear Receptor Signaling · doi:10.1621/nrs.06001 · Cited by 333
Self-citationCyclin D1 and prognosis in human breast cancer
Gillett, C., Smith, P., Gregory, W., Richards, M., Millis, R., Peters, G., & Barnes, D. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960422)69:2<92::aid-ijc4>3.0.co;2-q · Cited by 327
Genetics of hepatocellular tumors
Laurent-Puig, P., & Zucman-Rossi, J. (2006) · Oncogene · doi:10.1038/sj.onc.1209547 · Cited by 317
Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists
Chen, Y.-N. P., Sharma, S. K., Ramsey, T. M., Jiang, L., Martin, M. S., Baker, K., Adams, P. D., Bair, K. W., & Kaelin, W. G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.8.4325 · Cited by 314
(1995) · Lung Cancer · doi:10.1016/0169-5002(95)98734-r · Cited by 312
Life and death decisions by the E2F transcription factors
Iaquinta, P. J., & Lees, J. A. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.10.006 · Cited by 306
Herrera, R. E., Sah, V. P., Williams, B. O., Mäkelä, T. P., Weinberg, R. A., & Jacks, T. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.5.2402 · Cited by 304
Xu, Y., Chen, S.-Y., Ross, K. N., & Balk, S. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4472 · Cited by 301
Almasan, A., Yin, Y., Kelly, R. E., Lee, E. Y., Bradley, A., Li, W., Bertino, J. R., & Wahl, G. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5436 · Cited by 296
Coordinated regulation of life and death by RB
Chau, B. N., & Wang, J. Y. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc993 · Cited by 292
Hansen, J. B., Jørgensen, C., Petersen, R. K., Hallenborg, P., De Matteis, R., Bøye, H. A., Petrovic, N., Enerbäck, S., Nedergaard, J., Cinti, S., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0301964101 · Cited by 287
Knudsen, E. S., & Wang, J. Y. J. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.10.5771 · Cited by 286
Self-citationMitra, A. P., Datar, R. H., & Cote, R. J. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.2073 · Cited by 284
Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/−) mice
Yamasaki, L., Bronson, R., Williams, B. O., Dyson, N. J., Harlow, E., & Jacks, T. (1998) · Nature Genetics · doi:10.1038/ng0498-360 · Cited by 283
Chen, D., Livne-bar, I., Vanderluit, J. L., Slack, R. S., Agochiya, M., & Bremner, R. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.05.025 · Cited by 281
Molecular abnormalities in lung cancer.
Salgia, R., & Skarin, A. T. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.3.1207 · Cited by 276
Flesken‐Nikitin, A., Choi, K., Eng, J. P., Shmidt, E. N., & Nikitin, A. Y. (2003) · PubMed · Cited by 271
Lukas, J., Müller, H., Bartkova, J., Spitkovsky, D., Kjerulff, A. A., Jansen-Dürr, P., Strauss, M., & Bartek, J. (1994) · The Journal of cell biology · doi:10.1083/jcb.125.3.625 · Cited by 269
Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis.
Gansauge, S., Gansauge, F., Ramadani, M., Stobbe, H., Rau, B., Harada, N., & Beger, H. G. (1997) · PubMed · Cited by 261
Molecular prognostic markers in pancreatic cancer: A systematic review
Garcea, G., Neal, C. P., Pattenden, C. J., Steward, W. P., & Berry, D. P. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.04.044 · Cited by 259
Sutherland, R. L., & Musgrove, E. A. (2004) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/b:jomg.0000023591.45568.77 · Cited by 258
A gene-expression signature to predict survival in breast cancer across independent data sets
Naderi, A., Teschendorff, A. E., Barbosa-Morais, N. L., Pinder, S. E., Green, A. R., Powe, D. G., Robertson, J. F. R., Aparicio, S., Ellis, I. O., Brenton, J. D., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1209920 · Cited by 256
Chatterjee, S. J., Datar, R., Youssefzadeh, D., George, B., Goebell, P. J., Stein, J. P., Young, L., Shi, S.-R., Gee, C., Groshen, S., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.174 · Cited by 254
Developmental rescue of an embryonic-lethal mutation in the retinoblastoma gene in chimeric mice.
Maandag, E. C., van der Valk, M., Vlaar, M., Feltkamp, C., O'Brien, J., van Roon, M., van der Lugt, N., Berns, A., & te Riele, H. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06746.x · Cited by 248
Progression in Cutaneous Malignant Melanoma Is Associated with Distinct Expression Profiles
Alonso, S. R., Ortiz, P., Pollán, M., Pérez-Gómez, B., Sánchez, L., Acuña, M. J., Pajares, R., Martínez-Tello, F. J., Hortelano, C. M., Piris, M. A., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63110-0 · Cited by 244
Barnes, D. M., & Gillett, C. E. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1006103831990 · Cited by 243
pRB plays an essential role in cell cycle arrest induced by DNA damage
Harrington, E. A., Bruce, J. L., Harlow, E., & Dyson, N. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11945 · Cited by 242
[Molecular abnormalities in lung cancer].
Shimizu, S., & Mitsudomi, T. (2002) · PubMed · Cited by 235
Risk of Soft Tissue Sarcomas by Individual Subtype in Survivors of Hereditary Retinoblastoma
Kleinerman, R. A., Tucker, M. A., Abramson, D. H., Seddon, J. M., Tarone, R. E., & Fraumeni, J. F. (2007) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djk002 · Cited by 234
K-ras and p16 Aberrations Confer Poor Prognosis in Human Colorectal Cancer
Esteller, M., González, S., Risques, R. A., Marcuello, E., Mangues, R., Germà, J. R., Herman, J. G., Capellà, G., & Peinado, M. A. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.299 · Cited by 234
Rb and p16INK4a expression in resected non-small cell lung tumors.
Kratzke, R. A., Greatens, T. M., Rubins, J. B., Maddaus, M. A., Niewoehner, D. E., Niehans, G. A., & Geradts, J. (1996) · PubMed · Cited by 233
Management of Small Cell Lung Cancer
Simon, G. R., & Turrisi, A. (2007) · Chest · doi:10.1378/chest.07-1385 · Cited by 226
RB-Dependent S-Phase Response to DNA Damage
Knudsen, K. E., Booth, D., Naderi, S., Sever-Chroneos, Z., Fribourg, A. F., Hunton, I. C., Feramisco, J. R., Wang, J. Y. J., & Knudsen, E. S. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.20.7751-7763.2000 · Cited by 224
Self-citationCell type-specific effects of Rb deletion in the murine retina
MacPherson, D., Sage, J., Kim, T., Ho, D., McLaughlin, M. E., & Jacks, T. (2004) · Genes & Development · doi:10.1101/gad.1203304 · Cited by 222
Overexpression of cyclin D1 is associated with metastatic prostate cancer to bone.
Drobnjak, M., Osman, I., Scher, H. I., Fazzari, M. J., & Cordon‐Cardo, C. (2000) · PubMed · Cited by 221
The Petinoblastoma Tumor Suppressor Protein
(1994) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60834-9 · Cited by 219
Gauthier, M. L., Berman, H. K., Miller, C., Kozakeiwicz, K., Chew, K., Moore, D., Rabban, J., Chen, Y. Y., Kerlikowske, K., & Tlsty, T. D. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.10.017 · Cited by 214
Straume, O., Sviland, L., & Akslen, L. A. (2000) · PubMed · Cited by 209
Perreard, L., Fan, C., Quackenbush, J. F., Mullins, M., Gauthier, N. P., Nelson, E., Mone, M., Hansen, H., Buys, S. S., Rasmussen, K., et al. (2006) · Breast Cancer Research · doi:10.1186/bcr1399 · Cited by 205
Knudsen, K. E., Arden, K. C., & Cavenee, W. K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20213 · Cited by 204
Self-citationNovitch, B. G., Spicer, D. B., Kim, P. S., Cheung, W. L., & Lassar, A. B. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80210-3 · Cited by 199
The retinoblastoma tumor suppressor modifies the therapeutic response of breast cancer
Bosco, E. E., Wang, Y., Xu, H., Zilfou, J. T., Knudsen, K. E., Aronow, B. J., Lowe, S. W., & Knudsen, E. S. (2007) · Journal of Clinical Investigation · doi:10.1172/jci28803 · Cited by 192
Self-citationKnudsen, K. E., Cavenee, W. K., & Arden, K. C. (1999) · PubMed · Cited by 191
Self-citationFoster, J. S., Henley, D. C., Bukovsky, A., Seth, P., & Wimalasena, J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.3.794-810.2001 · Cited by 191
Reutens, A. T. (2001) · Molecular Endocrinology · doi:10.1210/me.15.5.797 · Cited by 189
Watts, C. K. (1995) · Molecular Endocrinology · doi:10.1210/me.9.12.1804 · Cited by 185
Paik, S. (2007) · The Oncologist · doi:10.1634/theoncologist.12-6-631 · Cited by 177
Lee, J.-S., & Thorgeirsson, S. S. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.015 · Cited by 173
Stendahl, M., Kronblad, Å., Rydén, L., Emdin, S., Bengtsson, N. O., & Landberg, G. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601831 · Cited by 169
Putting the Oncogenic and Tumor Suppressive Activities of E2F into Context
Johnson, D., & DeGregori, J. (2006) · Current Molecular Medicine · doi:10.2174/1566524010606070731 · Cited by 164
Kaye, F. J. (2002) · Oncogene · doi:10.1038/sj.onc.1205834 · Cited by 153
Dou, Q. P., An, B., & Will, P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9019 · Cited by 153
Kawesha, A., Ghaneh, P., Andrén‐Sandberg, Å., Ögraed, D., Skar, R., Dawiskiba, S., Evans, J. D., Campbell, F., Lemoine, N. R., & Neoptolemos, J. P. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20001120)89:6<469::aid-ijc1>3.0.co;2-l · Cited by 152
Phillips, S. M. A., Barton, C., Lee, S. J., Morton, D. G., Wallace, D., Lemoine, N. R., & Neoptolemos, J. P. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.482 · Cited by 152
Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1
Benzeno, S., Lu, F., Guo, M., Barbash, O., Zhang, F., Herman, J. G., Klein, P. S., Rustgi, A. K., & Diehl, J. A. (2006) · Oncogene · doi:10.1038/sj.onc.1209644 · Cited by 151
E2F-associated chromatin modifiers and cell cycle control
Blais, A., & Dynlacht, B. D. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.10.003 · Cited by 146
Cell cycle control and cancer.
Sherr, C. J. (2000) · PubMed · Cited by 145
Cyclin D1: Mechanism and Consequence of Androgen Receptor Co-repressor Activity
Petre, C. E., Wetherill, Y. B., Danielsen, M., & Knudsen, K. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106399200 · Cited by 144
Self-citationFunctional Identification of Api5 as a Suppressor of E2F-Dependent Apoptosis In Vivo
Morris, E. J., Michaud, W. A., Ji, J., Moon, N.-S., Rocco, J. W., & Dyson, N. J. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020196 · Cited by 143
Location, location, location: The role of cyclin D1 nuclear localization in cancer
Gladden, A. B., & Diehl, J. A. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20613 · Cited by 137
Hitting their targets: an emerging picture of E2F and cell cycle control
Blais, A., & Dynlacht, B. D. (2004) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2004.07.003 · Cited by 135
Tumor Suppressor Genes in Breast Cancer
Oliveira, A. M., Ross, J. S., & Fletcher, J. A. (2005) · Pathology Patterns Reviews · doi:10.1309/5xw3l8lu445qwgqr · Cited by 135
The transcription factor E2F-1 mediates the autoregulation of RB gene expression
Shan, B., Chang, C.-Y., Jones, D., & Lee, W. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.1.299-309.1994 · Cited by 132
Watts, C. K. W., Sweeney, K. J. E., Warlters, A., Musgrove, E. A., & Sutherland, R. L. (1994) · Breast Cancer Research and Treatment · doi:10.1007/bf00689680 · Cited by 131
The role of human papillomaviruses in human cancers
Münger, K. (2002) · Frontiers in bioscience · doi:10.2741/a800 · Cited by 130
RB in Breast Cancer: The Crossroads of Tumorigenesis and Treatment
Bosco, E. E., & Knudsen, E. S. (2007) · Cell Cycle · doi:10.4161/cc.6.6.3988 · Cited by 127
Self-citationAllelic loss of the retinoblastoma gene in primary human prostatic adenocarcinomas
Brooks, J. D., Bova, G. S., & Isaacs, W. B. (1995) · The Prostate · doi:10.1002/pros.2990260108 · Cited by 127
Straume, O., & Akslen, L. A. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19971021)74:5<535::aid-ijc10>3.0.co;2-5 · Cited by 124
Identification of Target Genes of the p16INK4A-pRB-E2F Pathway
Vernell, R., Helin, K., & Müller, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304930200 · Cited by 123
Craig, C., Kim, M., Ohri, E., Wersto, R. P., Katayose, D., Li, Z., Choi, Y. H., Mudahar, B., Srivastava, S. K., Seth, P. K., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1201493 · Cited by 123
Fujimoto, Y., Hampton, L. L., Wirth, P. J., Wang, N. J., Xie, J. P., & Thorgeirsson, S. S. (1994) · PubMed · Cited by 123
Markey, M. P., Angus, S. P., Strobeck, M. W., Williams, S., Gunawardena, R. W., Aronow, B. J., & Knudsen, E. S. (2002) · PubMed · Cited by 123
Self-citationCyclin D1 protein expression and gene polymorphism in colorectal cancer
McKay, J., Douglas, J. J., Ross, V. G., Curran, S., Murray, G. I., Cassidy, J., & Initiative, O. B. O. T. A. C. (2000) · International Journal of Cancer · Cited by 120
Hui, R., Macmillan, R. D., Kenny, F. S., Musgrove, E. A., Blamey, R. W., Nicholson, R. I., Robertson, J. F. R., & Sutherland, R. L. (2000) · PubMed · Cited by 120
Cyclin A is a prognostic indicator in early stage breast cancer with and without tamoxifen treatment
Michalides, R. J. A. M., van Tinteren, H., Balkenende, A., Vermorken, J. B., Benraadt, J., Huldij, J. C., & van Diest, P. J. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600072 · Cited by 115
Avni, D., Yang, H., Martelli, F., Hofmann, F., ElShamy, W. M., Ganesan, S., Scully, R., & Livingston, D. M. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00355-1 · Cited by 114
Azechi, H., Nishida, N., Fukuda, Y., Nishimura, T., Minata, M., Katsuma, H., Kuno, M., Ito, T., Komeda, T., Kita, R., et al. (2001) · Oncology · doi:10.1159/000058531 · Cited by 111
Hui, R., Finney, G. L., Carroll, J. S., Lee, C. S. L., Musgrove, E. A., & Sutherland, R. L. (2002) · PubMed · Cited by 109
Dublin, E. A., Patel, N. K., Gillett, C., Smith, P., Peters, G. G., & Barnes, D. M. (1998) · International Journal of Cancer · Cited by 109
New roles for the RB tumor suppressor protein
Liu, H., Dibling, B. C., Spike, B. T., Dirlam, A., & Macleod, K. F. (2003) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2003.11.005 · Cited by 107
Kaltz-Wittmer, C., Klenk, U., Glaessgen, A., Aust, D. E., Diebold, J., Löhrs, U., & Baretton, G. B. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780152 · Cited by 103
Balsitis, S. J., Sage, J., Duensing, S. M., Münger, K., Jacks, T., & Lambert, P. F. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.24.9094-9103.2003 · Cited by 103
Liver-Specific pRB Loss Results in Ectopic Cell Cycle Entry and Aberrant Ploidy
Mayhew, C. N., Bosco, E. E., Fox, S. R., Okaya, T., Tarapore, P., Schwemberger, S. J., Babcock, G. F., Lentsch, A. B., Fukasawa, K., & Knudsen, E. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4221 · Cited by 101
Self-citationDeeb, K. K., Michalowska, A. M., Yoon, C.-Y., Krummey, S. M., Hoenerhoff, M. J., Kavanaugh, C. J., Li, M., DeMayo, F. J., Linnoila, I. R., Deng, C., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1515 · Cited by 101
Role of pRB dephosphorylation in cell cycle regulation
Tamrakar, S., Rubin, E., & Ludlow, J. W. (2000) · Frontiers in bioscience · doi:10.2741/tamrakar · Cited by 99
Sgambato, A., Migaldi, M., Faraglia, B., Aloysio, G. D., Ferrari, P., Ardito, R., Gaetani, C. D., Capelli, G., Cittadini, A. R. M., & Trentini, G. P. (2001) · International Journal of Cancer · doi:10.1002/ijc.10055 · Cited by 98
Proliferation: the Most Prominent Predictor of Clinical Outcome in Breast Cancer
Desmedt, C., & Sotiriou, C. P. (2006) · Cell Cycle · doi:10.4161/cc.5.19.3254 · Cited by 97
RB signaling prevents replication-dependent DNA double-strand breaks following genotoxic insult
Bosco, E. E. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkg919 · Cited by 97
Identification of two distinct deleted regions on chromosome 13 in prostate cancer
Li, C., Larsson, C., Futreal, P. A., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1201554 · Cited by 96
Perturbation of cell cycle regulators in human cancer.
Palmero, I., & Peters, G. (1996) · PubMed · Cited by 95
Wang, J., Lee, J. J., Wang, L., Liu, D. D., Lu, C., Fan, Y.-H., Hong, W. K., & Mao, L. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0652 · Cited by 94
Cyclin D1 Expression in Breast Cancer Patients Receiving Adjuvant Tamoxifen-Based Therapy
Rudas, M., Lehnert, M., Huynh, A. T., Jakesz, R., Singer, C., Lax, S., Schippinger, W., Dietze, O., Greil, R., Stiglbauer, W., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4122 · Cited by 93
Retinoblastoma Tumor Suppressor Targets dNTP Metabolism to Regulate DNA Replication
Angus, S. P., Wheeler, L. J., Ranmal, S. A., Zhang, X., Markey, M. P., Mathews, C. K., & Knudsen, E. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205911200 · Cited by 91
Self-citationRb family proteins differentially regulate distinct cell lineages during epithelial development
Wikenheiser‐Brokamp, K. A. (2004) · Development · doi:10.1242/dev.01232 · Cited by 90
Kröger, N. M., Milde‐Langosch, K., Riethdorf, S., Schmoor, C., Schumacher, M. C., Zander, A. R., & Löning, T. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1340 · Cited by 90
Kitagawa, M., Aonuma, M., Lee, S. H., Fukutake, S., & McCormick, F. P. (2008) · Oncogene · doi:10.1038/onc.2008.164 · Cited by 89
p16INK4a is a Prognostic Marker in Resected Ductal Pancreatic Cancer
Gerdes, B., Ramaswamy, A., Ziegler, A., Lang, S. A., Kersting, M., Baumann, R., Wild, A., Moll, R., Rothmund, Μ., & Bartsch, D. K. (2002) · Annals of Surgery · doi:10.1097/00000658-200201000-00007 · Cited by 89
The prognostic significance of p34cdc2 and cyclin D1 protein expression in prostate adenocarcinoma
Kallakury, B., Sheehan, C. E., Ambros, R. A., Fisher, H. A. �., Kaufman, R. P., & Ross, J. S. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970815)80:4<753::aid-cncr15>3.0.co;2-s · Cited by 87
Sharma, A. M., Comstock, C. E. S., Knudsen, E. S., Cao, K. H., Hess-Wilson, J. K., Morey, L. M., Barrera, J. G., & Knudsen, K. E. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4424 · Cited by 87
Self-citationRB Loss Abrogates Cell Cycle Control and Genome Integrity to Promote Liver Tumorigenesis
Mayhew, C. N., Carter, S. L., Fox, S. R., Sexton, C. R., Reed, C. A., Srinivasan, S. V., Liu, X., Wikenheiser‐Brokamp, K. A., Boivin, G. P., Lee, J., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.06.025 · Cited by 87
Self-citationRetinoblastoma family proteins: insights gained through genetic manipulation of mice
Wikenheiser-Brokamp, K. A. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5487-3 · Cited by 85
Impact of differential cyclin D1 expression and localisation in prostate cancer
Comstock, C. E. S., Revelo, M. P., Buncher, C. R., & Knudsen, K. E. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603615 · Cited by 84
Self-citationSmall Molecule Inhibition of HDM2 Leads to p53-Mediated Cell Death in Retinoblastoma Cells
Elison, J. R., Cobrinik, D., Claros, N., Abramson, D. H., & Lee, T. C. (2006) · Archives of Ophthalmology · doi:10.1001/archopht.124.9.1269 · Cited by 82
Tut, V. M., Braithwaite, K. L., Angus, B., Neal, D. E., Lunec, J., & Mellon, J. K. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1557 · Cited by 82
TGF beta-induced growth inhibition in primary fibroblasts requires the retinoblastoma protein.
Herrera, R. E., Mäkelä, T. P., & Weinberg, R. A. (1996) · Molecular Biology of the Cell · doi:10.1091/mbc.7.9.1335 · Cited by 81
Kelley, M. J., Nakagawa, K., Steinberg, S., Mulshine, J. L., Kamb, A., & Johnson, B. E. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.10.756 · Cited by 80
The cyclin D1b splice variant: an old oncogene learns new tricks.
Knudsen, K. E. (2006) · Cell Division · doi:10.1186/1747-1028-1-15 · Cited by 79
Self-citationMarkey, M. P., Bergseid, J., Bosco, E. E., Stengel, K. R., Xu, H., Mayhew, C. N., Schwemberger, S. J., Braden, W. A., Jiang, Y., Babcock, G. F., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210450 · Cited by 78
Self-citationDistinct gene expression phenotypes of cells lacking Rb and Rb family members.
Black, E. P., Huang, E. S., Dressman, H. K., Rempel, R. E., Laakso, N., Asa, S. L., Ishida, S., West, M., & Nevins, J. R. (2003) · PubMed · Cited by 78
Hu, Y., Watanabe, H., Ohtsubo, K., Yamaguchi, Y., Ha, A., Okai, T., & Sawabu, N. (1997) · PubMed · Cited by 77
Molecular prognostication of liver cancer: End of the beginning
Thorgeirsson, S. S., Lee, J., & Grisham, J. W. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.01.008 · Cited by 73
p53 and Rb1 protein expression: are they prognostically useful in colorectal cancer?
Poller, D. N., Baxter, K. J., & Shepherd, N. A. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.14 · Cited by 72
Tan, A. R., Yang, X., Berman, A. W., Zhai, S., Sparreboom, A., Parr, A. L., Chow, C., Brahim, J. S., Steinberg, S. M., Figg, W. D., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0025 · Cited by 72
Reversing Drug Resistance In Vivo
Wendel, H.-G., & Lowe, S. W. (2004) · Cell Cycle · doi:10.4161/cc.3.7.976 · Cited by 70
Ritchie, C. K., Thomas, K. G., Andrews, L. R., Tindall, D. J., & Fitzpatrick, L. A. (1997) · The Prostate · doi:10.1002/(sici)1097-0045(19970215)30:3<188::aid-pros7>3.0.co;2-i · Cited by 68
Examination of the pRb-Dependent and pRb-Independent Functions of E7 In Vivo
Balsitis, S. J., Dick, F. A., Lee, D., Farrell, L., Hyde, R. K., Griep, A. E., Dyson, N. J., & Lambert, P. F. (2005) · Journal of Virology · doi:10.1128/jvi.79.17.11392-11402.2005 · Cited by 67
Pietiläinen, T., Lipponen, P., Aaltomaa, S. H., Eskelinen, M. J., Kosma, V., & Syrjänen, K. J. (1995) · European Journal of Cancer · doi:10.1016/0959-8049(94)00463-f · Cited by 67
Haddad, R. I., Weinstein, L. J., Wieczorek, T. J., Bhattacharya, N., Raftopoulos, H., Oster, M. W., Zhang, X., Latham, V. M., Costello, R., Faucher, J., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0229 · Cited by 66
Expression of p14ARF, p15INK4b, p16INK4a, and DCR2 increases during prostate cancer progression
Zhang, Z., Rosen, D. G., Yao, J. L., Huang, J., & Liu, J. (2006) · Modern Pathology · doi:10.1038/modpathol.3800655 · Cited by 65
Nguyen, V. N., Mirejovský, P., Miejovský, T., Melínová, L., & Mandys, V. (2000) · Acta Histochemica · doi:10.1078/s0065-1281(04)70039-2 · Cited by 65
ARF Is Not Required for Apoptosis in Rb Mutant Mouse Embryos
Tsai, K. Y., MacPherson, D. P., Rubinson, D. A., Crowley, D. G., & Jacks, T. (2002) · Current Biology · doi:10.1016/s0960-9822(01)00659-5 · Cited by 63
Moon, N.-S., Stefano, L. D., & Dyson, N. J. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00836-06 · Cited by 63
Overexpression of cyclin D1 is rare in human prostate carcinoma
Gumbiner, L. M., Gumerlock, P. H., Mack, P. C., Chi, S.-G., White, R. D., Mohler, J. L., Pretlow, T. G., & Tricoli, J. V. (1999) · The Prostate · doi:10.1002/(sici)1097-0045(19990101)38:1<40::aid-pros5>3.0.co;2-i · Cited by 59
Marino, S., Hoogervoorst, D., Brandner, S., & Berns, A. J. M. (2003) · Development · doi:10.1242/dev.00553 · Cited by 58
Somatic cell type specific gene transfer reveals a tumor‐promoting function for p21Waf1/Cip1
Liu, Y., Yeh, N., Zhu, X.-H., Leversha, M. A., Cordon‐Cardo, C., Ghossein, R. A., Singh, B., Holland, E. C., & Koff, A. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601886 · Cited by 56
UCN-01-mediated G1 arrest in normal but not tumor breast cells is pRb-dependent and p53-independent
Chen, X., Lowe, M., & Keyomarsi, K. (1999) · Oncogene · doi:10.1038/sj.onc.1202948 · Cited by 56
Andersson, S., Hansson, B., Norman, I., Gaberi, V., Mints, M., Hjerpe, A., Karlsen, F., & Johansson, B. (2006) · International Journal of Oncology · doi:10.3892/ijo.29.3.705 · Cited by 52
Chakravarti, A., DeSilvio, M., Zhang, M., Grignon, D. J., Rosenthal, S. A., Asbell, S. O., Hanks, G. E., Sandler, H. M., Khor, L.-Y., Pollack, A. S., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.4152 · Cited by 52
Jarrard, D. F., Modder, J. K., Fadden, P. T., Fu, V. X., Sebree, L., Heisey, D. M., Schwarze, S. R., & Friedl, A. (2002) · Cancer Letters · doi:10.1016/s0304-3835(02)00282-3 · Cited by 51
Derenzini, M., Donati, G., Mazzini, G., Montanaro, L., Vici, M., Ceccarelli, C., Santini, D., Taffurelli, M., & Treré, D. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-2065 · Cited by 50
RB activation defect in tumor cell lines
Broceño, C., Wilkie, S., & Mittnacht, S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212519499 · Cited by 47
Targeting MDM2 and MDMX in Retinoblastoma
Laurie, N. A., Schin-Shih, C., & Dyer, M. A. (2007) · Current Cancer Drug Targets · doi:10.2174/156800907782418266 · Cited by 46
RB status as a determinant of response to UCN-01 in non-small cell lung carcinoma.
Mack, P. C., Gandara, D. R., Bowen, C., Edelman, M. J., Paglieroni, T. G., Schnier, J. B., Gelmann, E. P., & Gumerlock, P. H. (1999) · PubMed · Cited by 44
ARF mutation accelerates pituitary tumor development in Rb +/− mice
Tsai, K. Y., MacPherson, D. P., Rubinson, D. A., Nikitin, A. Y., Bronson, R. T., Mercer, K. L., Crowley, D. G., & Jacks, T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.262499599 · Cited by 43
Aaltomaa, S. H., Kärjä, V. J., Lipponen, P., Isotalo, T., Kankkunen, J.-P., Talja, M. T., & Mokka, R. (2006) · PubMed · Cited by 41
Retinoblastoma Deficiency Increases Chemosensitivity in Lung Cancer
Zagórski, W., Knudsen, E. S., & Reed, M. F. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4753 · Cited by 40
Self-citationGene expression profiling in breast cancer
Sotiriou, C. P., & Desmedt, C. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl270 · Cited by 40
Discrete signaling pathways participate in RB-dependent responses to chemotherapeutic agents
Mayhew, C. N., Perkin, L. M., Zhang, X., Sage, J., Jacks, T., & Knudsen, E. S. (2004) · Oncogene · doi:10.1038/sj.onc.1207503 · Cited by 39
Self-citationLife, Death, and E2F: Linking Proliferation Control and DNA Damage Signaling via E2F1
Rogoff, H. A., & Kowalik, T. F. (2004) · Cell Cycle · doi:10.4161/cc.3.7.975 · Cited by 39
Cited by
Liquid biopsy: monitoring cancer-genetics in the blood
Crowley, E., Di Nicolantonio, F., Loupakis, F., & Bardelli, A. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.110 · Cited by 1,819
The history and future of targeting cyclin-dependent kinases in cancer therapy
Asghar, U., Witkiewicz, A. K., Turner, N. C., & Knudsen, E. S. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4504 · Cited by 1,767
Self-citationNon-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
Murtaza, M., Dawson, S.-J., Tsui, D. W. Y., Gale, D., Forshew, T., Piskorz, A. M., Parkinson, C., Chin, S.-F., Kingsbury, Z., Wong, A. S. C., et al. (2013) · Nature · doi:10.1038/nature12065 · Cited by 1,624
How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression
Aubrey, B. J., Kelly, G. L., Janic, A., Herold, M. J., & Strasser, A. (2018) · Cell Death & Differentiation · doi:10.1038/cdd.2017.169 · Cited by 1,395
Cyclin D as a therapeutic target in cancer
Musgrove, E. A., Caldon, C. E., Barraclough, J., Stone, A., & Sutherland, R. L. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3090 · Cited by 1,370
Metadata
- Authors
- Knudsen, E. S., & Knudsen, K. E.
- Venue
- Nature Reviews Cancer
- Published
- 2008-08-07
- Volume
- 8
- Issue
- 9
- Pages
- 714-724
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2079941948
- Cited by
- 344
- References
- 220
- FWCI
- 1.07
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.